• Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells.

    Thumbnail Image

    Files

    Breslin et al. 2013 - JCO.pdf (102.35 KB)

    Date

    2013

    Authors

    O'Driscoll, Lorraine

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Breslin S, Corcoran C, Rani S, Crown J, O?Driscoll L., Assessment of neratinib-resistance and cross-resistance in HER2-overexpressing breast cancer cells., J. Clin. Oncol., 31, 15, 2013, 11520 - 11521

    Abstract

    Description

    PUBLISHED

    URI

    http://hdl.handle.net/2262/76719

    Collections

    Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Author's Homepage: http://people.tcd.ie/lodrisc

    Author: O'Driscoll, Lorraine

    Other Titles: J. Clin. Oncol.
    Type of material: Published Abstract